Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pilar Fernandez-Perez"'
Autor:
Reheman Adili, Theodore R. Holman, Pilar Fernandez-Perez, Johnny Yu, Michael Holinstat, Benjamin E. Tourdot, Cody J. Freedman, Abigail R. Green, Jennifer Yeung
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 36:2068-2077
Objective— Dietary supplementation with polyunsaturated fatty acids has been widely used for primary and secondary prevention of cardiovascular disease in individuals at risk; however, the cardioprotective benefits of polyunsaturated fatty acids re
Autor:
Steven E. McKenzie, Benjamin E. Tourdot, Michael Holinstat, Pilar Fernandez-Perez, David G. Maloney, Jennifer Yeung, Theodore R. Holman
Publikováno v:
The FASEB Journal. 29
Autor:
David J. Maloney, Jennifer Yeung, Theodore R. Holman, Jin Ren, Benjamin E. Tourdot, Diane K. Luci, Ajit Jadhav, Joanne Vesci, Anton Simeonov, Steven E. McKenzie, Michael Holinstat, Pilar Fernandez-Perez, Christopher J. Smyrniotis
Publikováno v:
Blood. 124(14)
Platelets are essential in maintaining hemostasis following inflammation or injury to the vasculature. Dysregulated platelet activity often results in thrombotic complications leading to myocardial infarction and stroke. Activation of the FcγRIIa re
Autor:
Patrick L. Apopa, Michael Holinstat, Pilar Fernandez-Perez, Theodore R. Holman, Ajit Jadhav, Anton Simeonov, Jennifer Yeung, Joanne Vesci, Ganesha Rai, Olivier Boutaud, Moritz Stolla, David J. Maloney
SummaryFollowing initial platelet activation, arachidonic acid is metabolised by cyclooxygenase-1 and 12-lipoxygenase (12-LOX). While the role of 12-LOX in the platelet is not well defined, recent evidence suggests that it may be important for regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e1717844857ead059f96b4657854c5
https://europepmc.org/articles/PMC3960303/
https://europepmc.org/articles/PMC3960303/
Autor:
Theodore R. Holman, Michael Holinstat, Jin Ren, Jennifer Yeung, Pilar Fernandez-Perez, Joanne Vesci
Publikováno v:
Blood. 124:1436-1436
Platelet-mediated thrombosis is the primary underlying mechanism leading to cardiovascular life-threatening clinical events. Control of excessive platelet responses is an essential aspect of antithrombotic therapy. A number of anti-platelet drugs hav
Autor:
Ganesha Rai, Michael Holinstat, Theodore R. Holman, Ajit Jadhav, Anton Simeonov, David J. Maloney, Olivier Boutaud, Moritz Stolla, Joanne Vesci, Pilar Fernandez-Perez, Jennifer Yeung, Patrick L. Apopa
Publikováno v:
Thrombosis and Haemostasis. 112:426
Autor:
José A García-García, Marta Pérez-Quintana, Consuelo Ramos-Giráldez, Isabel Cebrián-González, María L Martín-Ponce, José del Valle-Villagrán, María A Navarro-Puerto, Jorge Sánchez-Villegas, Rocío Gómez-Herreros, Isabel Manoja-Bustos, Daniel León-Martí, Lucía Serrano-Rodríguez, Alejandra de Miguel-Albarreal, María J Velasco-Romero, Francisco Mula-Falcón, Pilar Fernández-Pérez, Isabel Melguizo-Moya, María J Pérez-Quintana, Guillermo Romero-Molina, Salvador Vergara-López, José L Marenco-de la Fuente, Jorge Marín-Martín, José A Mira-Escarti
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 17, p 4019 (2021)
Background: Immunomodulatory drugs have been used in patients with severe COVID-19. The objective of this study was to evaluate the effects of two different strategies, based either on an interleukin-1 inhibitor, anakinra, or on a JAK inhibitor, such
Externí odkaz:
https://doaj.org/article/33b890264581407484d0b7361c992a73